Optiscan Imaging (ASX:OIL) will showcase its product InSpecta, a novel microscopic imaging device designed specifically for the veterinary medicine market segment, at the American College of Veterinary Internal Medicine conference in Kentucky to be held from June 19 to 21, according to a Tuesday Australian bourse filing.
The device will be tested at the company's veterinary medicine partner institution, the University of Minnesota College of Veterinary Medicine, to help support regulatory submissions.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.